PHS44 Economic Evaluation of Universal Hepatitis B Vaccination Strategy in Japan
Tomohiro Hirao(Kagawa University), Shunya Ikeda(Hiroshima University), Manabu Akazawa(Meiji Pharmaceutical University), Tomotaka Sato(Kitasato University), Midori Kobayashi(FIND), Akira Yoshioka(Kyoto University), Machi Suka, Hiroki Sugimori(St. Marianna University School of Medicine), A. Igarashi(Tokyo University of Pharmacy and Life Sciences), Takeshi Yoda(Kagawa University)
Cited by 0
Related Papers
What has made the population of Japan healthy?
|The Lancet|2011|677
Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA.
|Proceedings of the National Academy of Sciences|1987|253
Adult Mortality Attributable to Preventable Risk Factors for Non-Communicable Diseases and Injuries in Japan: A Comparative Risk Assessment
|PLoS Medicine|2012|249
Whole-body MRI for Detecting Metastatic Bone Tumor: Diagnostic Value of Diffusion-weighted Images
|Magnetic Resonance in Medical Sciences|2007|181
The × Gene of Hepatitis B Virus Induced Growth Stimulation and Tumorigenic Transformation of Mouse NIH3T3 Cells
|Japanese Journal of Cancer Research|1989|170